225 related articles for article (PubMed ID: 25342852)
1. Visceral adiposity index and DHEAS are useful markers of diabetes risk in women with polycystic ovary syndrome.
Amato MC; Magistro A; Gambino G; Vesco R; Giordano C
Eur J Endocrinol; 2015 Jan; 172(1):79-88. PubMed ID: 25342852
[TBL] [Abstract][Full Text] [Related]
2. Metabolically healthy polycystic ovary syndrome (MH-PCOS) and metabolically unhealthy polycystic ovary syndrome (MU-PCOS): a comparative analysis of four simple methods useful for metabolic assessment.
Amato MC; Guarnotta V; Forti D; Donatelli M; Dolcimascolo S; Giordano C
Hum Reprod; 2013 Jul; 28(7):1919-28. PubMed ID: 23592224
[TBL] [Abstract][Full Text] [Related]
3. Lipid Accumulation Product (LAP) and Visceral Adiposity Index (VAI) as Markers of Insulin Resistance and Metabolic Associated Disturbances in Young Argentine Women with Polycystic Ovary Syndrome.
Abruzzese GA; Cerrrone GE; Gamez JM; Graffigna MN; Belli S; Lioy G; Mormandi E; Otero P; Levalle OA; Motta AB
Horm Metab Res; 2017 Jan; 49(1):23-29. PubMed ID: 27571188
[TBL] [Abstract][Full Text] [Related]
4. Effects of race and family history of type 2 diabetes on metabolic status of women with polycystic ovary syndrome.
Ehrmann DA; Kasza K; Azziz R; Legro RS; Ghazzi MN;
J Clin Endocrinol Metab; 2005 Jan; 90(1):66-71. PubMed ID: 15507516
[TBL] [Abstract][Full Text] [Related]
5. The visceral adiposity index as a predictor of insulin resistance in young women with polycystic ovary syndrome.
Oh JY; Sung YA; Lee HJ
Obesity (Silver Spring); 2013 Aug; 21(8):1690-4. PubMed ID: 23585246
[TBL] [Abstract][Full Text] [Related]
6. A visceral adiposity index-related dietary pattern and the cardiometabolic profiles in women with polycystic ovary syndrome.
Ehsani B; Moslehi N; Mirmiran P; Ramezani Tehrani F; Tahmasebinejad Z; Azizi F
Clin Nutr; 2016 Oct; 35(5):1181-7. PubMed ID: 26699405
[TBL] [Abstract][Full Text] [Related]
7. Oral glucose tolerance test significantly impacts the prevalence of abnormal glucose tolerance among Indian women with polycystic ovary syndrome: lessons from a large database of two tertiary care centers on the Indian subcontinent.
Ganie MA; Dhingra A; Nisar S; Sreenivas V; Shah ZA; Rashid A; Masoodi S; Gupta N
Fertil Steril; 2016 Jan; 105(1):194-201.e1-3. PubMed ID: 26407537
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women.
Legro RS; Kunselman AR; Dodson WC; Dunaif A
J Clin Endocrinol Metab; 1999 Jan; 84(1):165-9. PubMed ID: 9920077
[TBL] [Abstract][Full Text] [Related]
9. The Role of Visceral Adiposity Index as Predictor of Metabolic Syndrome in Obese and Nonobese Women with Polycystic Ovary Syndrome.
de Medeiros SF; de Medeiros MAS; Barbosa BB; Yamamoto MMW
Metab Syndr Relat Disord; 2021 Feb; 19(1):18-25. PubMed ID: 32845813
[No Abstract] [Full Text] [Related]
10. Retinol-binding protein 4 is associated with insulin resistance, but appears unsuited for metabolic screening in women with polycystic ovary syndrome.
Möhlig M; Weickert MO; Ghadamgahi E; Arafat AM; Spranger J; Pfeiffer AF; Schöfl C
Eur J Endocrinol; 2008 Apr; 158(4):517-23. PubMed ID: 18362299
[TBL] [Abstract][Full Text] [Related]
11. Progression to impaired glucose tolerance or type 2 diabetes mellitus in polycystic ovary syndrome: a controlled follow-up study.
Celik C; Tasdemir N; Abali R; Bastu E; Yilmaz M
Fertil Steril; 2014 Apr; 101(4):1123-8.e1. PubMed ID: 24502891
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of a new anthropometric indicator - VAI (Visceral Adiposity Index) in the evaluation of metabolic and hormonal disorders in women with polycystic ovary syndrome.
Brończyk-Puzoń A; Jagielski P; Kulik-Kupka K; Koszowska A; Nowak J; Zubelewicz-Szkodzińska B
Adv Clin Exp Med; 2017 Aug; 26(5):825-828. PubMed ID: 29068579
[TBL] [Abstract][Full Text] [Related]
13. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.
Shi Y; Guo M; Yan J; Sun W; Zhang X; Geng L; Xu L; Chen Z
Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948
[TBL] [Abstract][Full Text] [Related]
14. Visceral Adiposity Measurements, Metabolic and Inflammatory Profi le in Obese Patients with and Without Type 2 Diabetes Mellitus: A Crosssectional Analysis.
Wanderley Rocha DR; Jorge AR; Braulio VB; Arbex AK; Marcadenti A
Curr Diabetes Rev; 2017; 13(1):11-18. PubMed ID: 26467189
[TBL] [Abstract][Full Text] [Related]
15. Association between visceral adiposity index, hirsutism and cardiometabolic risk factors in women with polycystic ovarian syndrome: A cross-sectional study.
Fonseka S; Subhani B; Wijeyaratne CN; Gawarammana IB; Kalupahana NS; Ratnatunga N; Rosairo S; Vithane KP
Ceylon Med J; 2019 Sep; 64(3):111-117. PubMed ID: 32120461
[TBL] [Abstract][Full Text] [Related]
16. The prevalence of glucose metabolism abnormalities in Greek women with polycystic ovary syndrome.
Trakakis E; Basios G; Peppa M; Simeonidis G; Labos G; Creatsa M; Misailidou M; Boutati E; Vaggopoulos V; Panagopoulos P; Dimitriades G; Kassanos D
Gynecol Endocrinol; 2012 Nov; 28(11):867-70. PubMed ID: 22571176
[TBL] [Abstract][Full Text] [Related]
17. Visceral adiposity index (VAI) is related to the severity of anovulation and other clinical features in women with polycystic ovary syndrome.
Androulakis II; Kandaraki E; Christakou C; Karachalios A; Marinakis E; Paterakis T; Diamanti-Kandarakis E
Clin Endocrinol (Oxf); 2014 Sep; 81(3):426-31. PubMed ID: 24601936
[TBL] [Abstract][Full Text] [Related]
18. Assessment of glucose metabolism in polycystic ovary syndrome: HbA1c or fasting glucose compared with the oral glucose tolerance test as a screening method.
Lerchbaum E; Schwetz V; Giuliani A; Obermayer-Pietsch B
Hum Reprod; 2013 Sep; 28(9):2537-44. PubMed ID: 23756702
[TBL] [Abstract][Full Text] [Related]
19. The prevalence of Type 2 diabetes is not increased in normal-weight women with PCOS.
Pelanis R; Mellembakken JR; Sundström-Poromaa I; Ravn P; Morin-Papunen L; Tapanainen JS; Piltonen T; Puurunen J; Hirschberg AL; Fedorcsak P; Andersen M; Glintborg D
Hum Reprod; 2017 Nov; 32(11):2279-2286. PubMed ID: 29040530
[TBL] [Abstract][Full Text] [Related]
20. Dietary glycemic index is associated with less favorable anthropometric and metabolic profiles in polycystic ovary syndrome women with different phenotypes.
Graff SK; Mário FM; Alves BC; Spritzer PM
Fertil Steril; 2013 Oct; 100(4):1081-8. PubMed ID: 23830153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
